India's Drug Safety: DCGI Mandates Digital Monitoring of High-Risk Solvents
UPSC Relevance
Prelims: Governance (Public Health, Digital Initiatives); Science & Technology (Key Regulatory Bodies - DCGI, Chemicals in News - Diethylene Glycol).
Mains:
General Studies Paper 2 (Governance & Social Justice): Issues relating to development and management of Social Sector/Services relating to Health; Government policies and interventions.
General Studies Paper 3 (Economy): Issues related to the pharmaceutical industry; Science and Technology- developments and their applications and effects in everyday life.
Key Highlights from the News
The Drugs Controller General (India) - DCGI has mandated digital monitoring to oversee the supply chain of high-risk solvents used in pharmaceuticals.
This action follows the death of 20 children in Madhya Pradesh due to the contamination of cough syrups with the toxic substance Diethylene Glycol (DEG).
This monitoring will be implemented through a single-window portal called the Online National Drugs Licensing System (ONDLS).
The new order mandates that all manufacturers producing pharma-grade solvents must obtain a license or register on the ONDLS portal.
COMMENTS